FREE delivery to all EXCLUSIVE BOOKS stores nationwide. FREE delivery to your door on all orders over R450. Excludes all international deliveries.

Combination Cancer Therapy

Gary K. Schwartz
    Product form
      FORMAT: Hardback

      R 4,652.67 Price and availability exclusive to website

      YOU COULD EARN 4,652.67 FUTURE RETAIL DISCOUNTS.
      ESTIMATED DELIVERY: Approx. 10 - 15 Business Days
      BUY NOW PAY LATER
      From R 775.44 per month!
      3x monthly payments of R 1,550.89 with
      4x fortnightly payments of R 1,163.16 with
      Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory bench top to the patient's bedside for the future treatments in cancer therapy.
      Format: Hardback CONTRIBUTORS: Gary K. Schwartz EAN: 9781588292001 COUNTRY: United States PAGES: WEIGHT: 1310 g HEIGHT: 235 cm
      PUBLISHED BY: Humana Press Inc. DATE PUBLISHED: 2004-12-03 CITY: GENRE: MEDICAL / Oncology / General WIDTH: 155 cm SPINE:

      Book Themes:

      Oncology

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory bench top to the patient's bedside for the future treatments in cancer therapy.
      Format: Hardback CONTRIBUTORS: Gary K. Schwartz EAN: 9781588292001 COUNTRY: United States PAGES: WEIGHT: 1310 g HEIGHT: 235 cm
      PUBLISHED BY: Humana Press Inc. DATE PUBLISHED: 2004-12-03 CITY: GENRE: MEDICAL / Oncology / General WIDTH: 155 cm SPINE:

      Book Themes:

      Oncology

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)

      Recently viewed products

      Login

      Forgot your password?

      Don't have an account yet?
      Create account